title: [Phosphate binders in chronic kidney disease: the positions of sevelamer].
abstract: The paper shows the role of phosphate binders in the correction of phosphorus and calcium metabolic disturbances in chronic kidney disease. The results of clinical trials demonstrating the efficacy and safety of sevelamer are discussed.
authors.forename: V V
authors.initials: VV
authors.lastname: Fomin
authors.forename: E M
authors.initials: EM
authors.lastname: Shilov
authors.forename: A A
authors.initials: AA
authors.lastname: Svistunov
authors.forename: Iu S
authors.initials: IuS
authors.lastname: Milovanov
mesh_terms: D002118:Calcium / Q000097:blood; D002614:Chelating Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D054559:Hyperphosphatemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D010710:Phosphates / Q000097:blood*; D011073:Polyamines / Q000008:administration & dosage / Q000627:therapeutic use*; D051436:Renal Insufficiency, Chronic / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D000069603:Sevelamer
chemical_list: D002614:Chelating Agents; D010710:Phosphates; D011073:Polyamines; D000069603:Sevelamer; D002118:Calcium